1,428 research outputs found

    Resonance breaking due to dissipation in planar planetary systems

    Full text link
    We study the evolution of two planets around a star, in mean-motion resonance and undergoing tidal effect. We derive an integrable analytical model of mean-motion resonances of any order which reproduce the main features of the resonant dynamics. Using this simplified model, we obtain a criterion showing that depending on the balance of the tidal dissipation in both planets, their final period ratio may stay at the resonant value, increase above, or decrease below the resonant value. Applying this criterion to the two inner planets orbiting GJ163, we deduce that the current period ratio (2.97) could be the outcome of dissipation in the 3:1 MMR provided that the innermost planet is gaseous (slow dissipation) while the second one is rocky (faster dissipation). We perform N-body simulations with tidal dissipation to confirm the results of our analytical model. We also apply our criterion on GJ581b, c (5:2 MMR) and reproduce the current period ratio (2.4) if the inner planet is gaseous and the outer is rocky (as for GJ163). Finally, we apply our model to the Kepler mission's statistics. We show that the excess of planets pairs close to first order MMR but in external circulation, i.e., with period ratios P_out/P_in > (p+1)/p for the resonance (p+1):p, can be reproduced by tidal dissipation in the inner planet. There is no need for any other dissipative mechanism, provided that these systems left the resonance with non-negligible eccentricities.Comment: 14 pages, 9 figures, submitted for publicatio

    The Effect of Age on Recovery of Heart Rate After Exercise

    Get PDF
    The purpose of this study was to determine if heart rate recovery, following exercise, of active women aged between 50-63 years was significantly slower than the recovery of active women aged 23-24 years when both groups exercised at the same relative perceived intensity. Ten female subjects, five young and five older, were tested during a five minute bout of treadmill exercise while working at a rating of perceived exertion(RPE) of 14. Heart rate was measured prior to and during testing and into recovery using the Vantage Performance Monitor. The time, measured in seconds, it took for each subject to drop 50% from their steady state heart rate to their pre-exercise heart rate was determined. An independent t-test was used to determine if there was a significant differences in rate of recovery between the young and older women. There were no statistically significant differences (

    Editors\u27 Note

    Get PDF

    Editors\u27 Note

    Get PDF

    Book Reviews

    Get PDF
    Book Reviews of: Carol Tavris, Anger: The Misunderstood Emotion (Simon & Schuster, 1982) John Fowles, A Maggot (Little-Brown, 1985) James Q. Wilson and Richard J. Herrnstein, Crime and Human Nature (Simon & Schuster, 1985

    New solution of the N=2\mathcal{N}=2 Supersymmetric KdV equation via Hirota methods

    Full text link
    We consider the resolution of the N=2\mathcal{N}=2 supersymmetric KdV equation with a=−2a=-2 (SKdVa=−2SKdV_{a=-2}) from the Hirota formalism. For the first time, a bilinear form of the SKdVa=−2SKdV_{a=-2} equation is constructed. We construct multisoliton solutions and rational similarity solutions.Comment: 7 pages, 9 figures. arXiv admin note: significant text overlap with arXiv:1104.059

    Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.

    Get PDF
    BackgroundEarly detection of adverse effects of novel therapies and understanding of their mechanisms could improve the safety and efficiency of drug development. We have retrospectively applied large-scale proteomics to blood samples from ILLUMINATE (Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events), a trial of torcetrapib (a cholesterol ester transfer protein inhibitor), that involved 15 067 participants at high cardiovascular risk. ILLUMINATE was terminated at a median of 550 days because of significant absolute increases of 1.2% in cardiovascular events and 0.4% in mortality with torcetrapib. The aims of our analysis were to determine whether a proteomic analysis might reveal biological mechanisms responsible for these harmful effects and whether harmful effects of torcetrapib could have been detected early in the ILLUMINATE trial with proteomics.MethodsA nested case-control analysis of paired plasma samples at baseline and at 3 months was performed in 249 participants assigned to torcetrapib plus atorvastatin and 223 participants assigned to atorvastatin only. Within each treatment arm, cases with events were matched to controls 1:1. Main outcomes were a survey of 1129 proteins for discovery of biological pathways altered by torcetrapib and a 9-protein risk score validated to predict myocardial infarction, stroke, heart failure, or death.ResultsPlasma concentrations of 200 proteins changed significantly with torcetrapib. Their pathway analysis revealed unexpected and widespread changes in immune and inflammatory functions, as well as changes in endocrine systems, including in aldosterone function and glycemic control. At baseline, 9-protein risk scores were similar in the 2 treatment arms and higher in participants with subsequent events. At 3 months, the absolute 9-protein derived risk increased in the torcetrapib plus atorvastatin arm compared with the atorvastatin-only arm by 1.08% (P=0.0004). Thirty-seven proteins changed in the direction of increased risk of 49 proteins previously associated with cardiovascular and mortality risk.ConclusionsHeretofore unknown effects of torcetrapib were revealed in immune and inflammatory functions. A protein-based risk score predicted harm from torcetrapib within just 3 months. A protein-based risk assessment embedded within a large proteomic survey may prove to be useful in the evaluation of therapies to prevent harm to patients.Clinical trial registrationURL: https://www.clinicaltrials.gov. Unique identifier: NCT00134264

    Chemical and toxicological characterization of the lower Mobjack Bay, York River, Virginia segment of the Chesapeake Bay

    Get PDF
    The Chesapeake Bay segment called Lower Mobjack Bay Lower York River Virginia was found to have insufficient data to characterize in 1999. Therefore this area was selected for a chemical, toxicological, benthic community characterization study of the sediments in 2002. The segment was divided into 3 strata: the lower York River, the Poquoson River, and Back River, each with 4 randomly selected stations. Samples were collected in October 2002 for evaluation of conditions. There were few significant chemical exceedances of the ER-L or ER-M in the three strata and no toxicologically effects from exposure to sediment samples from any stratum. In contrast, the Poquoson and Back River strata showed consistent community degradation ranging from degraded to seriously degraded. The lack of chemical and toxicological impacts and the intensive residential land use makes it reasonable to conclude that the likely explanation for the degraded benthic community is eutrophication. There is not, however, confirmatory data for this interpretation
    • …
    corecore